Hepatic HMOX1 expression positively correlates with Bach-1 and miR-122 in patients with HCV mono and HIV/HCV coinfection

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Jabłonowska, Elzbieta ^a   Wójcik, Kamila ^a   Szymańska, Bozena ^a   Omulecka, Aleksandra ^b   Ćwiklińska, Hanna ^a   Piekarska, Anna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Provincial Specialist Hospital   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BACH 1 PROTEIN; HEME OXYGENASE 1; INTERLEUKIN 28B; MICRORNA 22; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG; BACH1 PROTEIN, HUMAN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; FANCONI ANEMIA PROTEIN; HMOX1 PROTEIN, HUMAN; MICRORNA; MIRN122 MICRORNA, HUMAN;

ADULT; ARTICLE; BACH 1 GENE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEPATITIS C; HISTOPATHOLOGY; HMOX1 GENE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD; VIRUS PATHOGENESIS; COMPLICATION; DEMOGRAPHY; GENETICS; IMMUNOLOGY; LIVER; METABOLISM; MIDDLE AGED; VIROLOGY;

ADULT; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CD4 LYMPHOCYTE COUNT; COINFECTION; DEMOGRAPHY; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FEMALE; HEME OXYGENASE-1; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER; MALE; MICRORNAS; MIDDLE AGED; VIRAL LOAD;

EID: 84899678618     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095564     Document Type: Article

References (32)

1. Chen SL, Morgan TR (2006) The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 3: 47-52.
2. Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345: 41-52. (Pubitemid 32634271)
3. Koziel MJ, Peters MG (2007) Viral hepatitis in HIV infection. N Engl J Med 356: 1445-1454. (Pubitemid 46556329)
4. Caballeria L, Pares A, Castells A, Gines A, Bru C, et al. (2001) Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis. Am J Gastroenterol 96: 1160-1163. (Pubitemid 32319154)
5. Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, et al. (2011) Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 364: 2405-2416.
6. Poordad F, McCone J, Jr., Bacon BR, Bruno S, Manns MP, et al. (2011) Boceprevir foruntreated chronic HCV genotype 1 infection. N Engl J Med 364: 1195-1206.
7. Choi J, Lee KJ, Zheng Y, Yamaga AK, Lai MM, et al. (2004) Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology 39: 81-89. (Pubitemid 38461470)
8. Mutlu-Turkoglu U, Ademoglu E, Turkoglu S, Badur S, Uysal M, et al. (1997) The effects of interferonalpha on serum lipid peroxidation and total thiol content in patients with chronic active hepatitis-C. Res Commun Mol Pathol Pharmacol 96: 357-361. (Pubitemid 27329989)
9. De Maria N, Colantoni A, Fagiuoli S, Liu GJ, Rogers BK, et al. (1996) Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 21: 291-295. (Pubitemid 26271718)
10. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, et al. (1995) Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 22: 449-456.
11. Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, et al. (1994) Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res 54: 3171-3172. (Pubitemid 24208923)
12. Wen T, Zhao JY, Mei S, Guan L, Zhang YL (2006) [Protective effect of heme oxygenase-1 and its reaction product, carbon monoxide on acute liver injury induced by carbon tetrachloride in rats]. Beijing Da Xue Xue Bao 38: 618-622.
13. Abraham NG, Kappas A (2008) Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60: 79-127. (Pubitemid 351439218)
14. Zhu Z, Wilson AT, Mathahs MM, Wen F, Brown KE, et al. (2008) Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury. Hepatology 48: 1430-1439.
15. Shan Y, Zheng J, Lambrecht RW, Bonkovsky HL (2007) Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology 133: 1166-1174. (Pubitemid 47494462)
16. Ghaziani T, Shan Y, Lambrecht RW, Donohue SE, Pietschmann T, et al. (2006) HCV proteins increase expression of heme oxygenase-1 (HO-1) and decrease expression of Bach1 in human hepatoma cells. J Hepatol 45: 5-12. (Pubitemid 43850616)
17. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W (2009) Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 15: 31-33.
18. Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19: 1409-1417.
19. Korenaga M, Wang T, Li Y, Showalter LA, Chan T, et al. (2005) Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 280: 37481-37488. (Pubitemid 41642356)
20. Elbirt KK, Bonkovsky HL (1999) Heme oxygenase: recent advances in understanding its regulation and role. Proc Assoc Am Physicians 111: 438-447. (Pubitemid 29446887)
21. Takahashi T, Shimizu H, Morimatsu H, Inoue K, Akagi R, et al. (2007) Heme oxygenase-1: a fundamental guardian against oxidative tissue injuries in acute inflammation. Mini Rev Med Chem 7: 745-753. (Pubitemid 47099174)
22. Abdalla MY, Ahmad IM, Spitz DR, Schmidt WN, Britigan BE (2005) Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses. J Med Virol 76: 489-497. (Pubitemid 40943258)
23. Abdalla MY, Britigan BE, Wen F, Icardi M, McCormick ML, et al. (2004) Down-regulation of heme oxygenase-1 by hepatitis C virus infection in vivo and by the in vitro expression of hepatitis C core protein. J Infect Dis 190: 1109-1118. (Pubitemid 39186798)
24. Hou WH, Rossi L, Shan Y, Zheng JY, Lambrecht RW, et al. (2009) Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells. World J Gastroenterol 15: 4499-4510.
25. Zhu Z, Wilson AT, Luxon BA, Brown KE, Mathahs MM, et al. (2010) Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase? Hepatology 52: 1897-1905.
26. Fillebeen C, Pantopoulos K (2010) Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells. J Hepatol 53: 995-999.
27. Lehmann E, El-Tantawy WH, Ocker M, Bartenschlager R, Lohmann V, et al. (2010) The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response. Hepatology 51: 398-404.
28. Kakizaki S, Takagi H, Horiguchi N, Toyoda M, Takayama H, et al. (2000) Iron enhances hepatitis C virus replication in cultured human hepatocytes. Liver 20: 125-128. (Pubitemid 30219138)
29. Jopling CL, Norman KL, Sarnow P (2006) Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122. Cold Spring Harb Symp Quant Biol 71: 369-376.
30. Roberts AP, Lewis AP, Jopling CL (2011) miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components. Nucleic Acids Res 39: 7716-7729.
31. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, et al. (2007) Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449: 919-922. (Pubitemid 47598616)
32. Devadas K, Dhawan S (2006) Hemin activation ameliorates HIV-1 infection via heme oxygenase-1 induction. J Immunol 176: 4252-4257. (Pubitemid 44264404)